Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

labrafac WL 1349

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The aim of the present study was to optimize the size and polydispersity of a lipid nanoemulsion as a function of the oil… Expand
Is this relevant?
2017
2017
In the present study, various nanoemulsions were prepared using Labrafac PG+Triacetin as oil, Tween 80 as a surfactant and… Expand
  • figure 2
  • figure 4
  • figure 5
  • figure 6
  • figure 7
Is this relevant?
2016
2016
Abstract Objective: In the present study, Curcumin (CU)-loaded nanocarrier (NC) such as nanoemulsion (NE) was developed with the… Expand
Is this relevant?
2013
2013
Efavirenz is an antiretroviral drug which exhibits lower absorption in gastric fluid due to poor water solubility characteristics… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 5
Is this relevant?
Highly Cited
2012
Highly Cited
2012
A new delivery system based on drug cyclodextrin (Cd) complexation and loading into nanostructured lipid carriers (NLC) has been… Expand
Is this relevant?
2012
2012
Context: An adequate drug dissolution behavior is essential for the therapeutic effectiveness of all solid dosage forms… Expand
Is this relevant?
2012
2012
To develop strategies for selecting appropriate lipids from mono-, di- and tri-esters of medium-chain fatty acids for the… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
The present work was aimed at formulating a SMEDDS (self-microemulsifying drug delivery system) of fenofibrate and evaluating its… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
The objective of the present investigation was to clarify the mechanism by which Labrafac Lipophile WL 1349 (WL 1349) enhanced… Expand
Is this relevant?
2006
2006
The purpose of the present work is to develop nanoparticles of a new antitubulin agent of the family of tripentones by means of a… Expand
Is this relevant?